Low vitamin d status predicts poor clinical outcome in advanced melanoma treated with immune checkpoint or braf/mek inhibitors: a prospective non-interventional side-by-side analysis

HIGHLIGHTS

• who: Jörg Reichrath from the Universidade Estadual do Oeste do Paraná, Brazil have published the Article: Low Vitamin D Status Predicts Poor Clinical Outcome in Advanced Melanoma Treated With Immune Checkpoint or BRAF/MEK Inhibitors: A Prospective Non-Interventional Side-by-Side Analysis, in the Journal: (JOURNAL)
• what: The authors show in this comparative, non-interventional, side-by-side analysis that low vitamin D status is a strong predictor of poor outcome in patients treated for advanced melanoma with BRAFi, MEKi, CTLA-4i, and/or PD-1i. It was demonstrated that vitamin D is . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.